5:40 PM
 | 
Feb 18, 2010
 |  BC Extra  |  Company News

FDA approves Rituxan sBLAs

FDA approved a pair of sBLAs from Genentech Inc. and partner Biogen Idec Inc. (NASDAQ:BIIB) for

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >